Exponent (EXPO) EBT (2010 - 2026)

Exponent has disclosed EBT across 17 years of filings, most recently posting $42.3 million for Q2 2026.

• Quarterly EBT rose 12.13% year-over-year to $42.3 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $14.8 million (down 89.78% YoY) and the FY2026 annual result came in at $10.2 million, down 93.07% from the prior year.
• EBT rose to $42.3 million in Q2 2026, from -$103.0 million in the prior quarter.
• Over five years, EBT peaked at $42.3 million in Q2 2026 and troughed at -$103.0 million in Q1 2026.
• A 5-year average of $27.5 million and a median of $35.5 million in 2023 frame the typical range for EBT.
• Annual changes were most pronounced in 2024 — EBT advanced 13.75% — and 2026, when it slumped 428.71%.
• Tracing EXPO's EBT over 5 years: stood at $30.5 million in 2022, then retreated by 1.41% to $30.1 million in 2023, then rose by 19.44% to $35.9 million in 2024, then grew by 7.46% to $38.6 million in 2025, then increased by 9.64% to $42.3 million in 2026.
• Business Quant data shows EXPO's EBT at $42.3 million in Q2 2026, -$103.0 million in Q1 2026, and $38.6 million in Q4 2025.